Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II open-label ARA 290 study in active rheumatoid arthritis
NL-OMON36765Phase 2Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Jul 2011
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of cibinetide in rheumatoid arthritis (RA), sponsored by Leiden University Medical Center. Started Jul 2011; status: active, not recruiting.
02
Drugs
cibinetide
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NL-OMON36765.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36765.